Schedule 13D ownership disclosure
X4 PHARMACEUTICALS INC
Security class unavailable · CUSIP: 98420X103
Event date: 2019-03-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-195714
- Form type
- SC 13D
- Filer
- Polaris Venture Partners V, L.P.
- CIK
- CIK 1439590
- Filed
- Jul 17, 2019
- Reporting period
- Mar 13, 2019
- Description
- Schedule 13D beneficial ownership